Skip to content

Lateral Window Versus Intralift™ Sinus Floor Elevation

Intraoperative and Postoperative Outcomes of Sinus Floor Elevation Using Lateral Window Technique Versus Hydrodynamic Transalveolar Approach: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04499625
Enrollment
22
Registered
2020-08-05
Start date
2013-05-31
Completion date
2018-05-31
Last updated
2020-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraoperative Outcomes, Postoperative Outcomes

Brief summary

Several approaches have been used in order to regenerate bone in the upper jaw in case of insufficient alveolar bone height for implant placement. However, new emerging techniques need to be assessed and compared to conventional methods in order to define their potential indications. The purpose of the present randomized controlled clinical trial was to compare the clinical outcomes of two sinus floor elevation techniques: conventional lateral window technique versus a novel transalveolar approach using hydrodynamic ultrasonic device.

Interventions

DEVICESinus floor elevation using an ultrasonic device

Sponsors

University of Liege
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* edentulism in the posterior maxilla (unitary or plural) * need of a sinus floor augmentation procedure before implant placement

Exclusion criteria

* any uncontrolled systemic disease * ongoing chemo- or radiotherapy * history of maxillary sinus diseases or acute sinus-related issues

Design outcomes

Primary

MeasureTime frameDescription
Patient related outcome measures (PROMs)From right before the surgery up to 1 week postoperativelyPROMs were assessed with a questionnaire using a visual analogue scale (VAS), which was given to all participants in order to assess their perception before, during, and after the intervention. A graduated scale from 0 to 10 was used, with a lower score presenting a better outcome.
Nasal dischargeFrom the end of surgery up to 1 week postoperativelyPresence/absence of nasal discharge postoperatively
NSAID consumptionFrom the end of surgery up to 1 week postoperativelyQuantification of NSAID consumption per day up to 1 week postoperatively (tablets/per day)
Sinus membrane perforationDuring the surgery (from beginning to end)Presence/absence of sinus membrane perforation during the surgery
Surgical procedure durationFrom beginning of surgery until the end of surgeryThe time measurement started from the administration of local anesthesia and ended when the placement of final suture was completed. The time was measured using a stopwatch.
EdemaFrom the end of surgery up to 1 week postoperativelyPresence/absence of edema postoperatively
HematomaFrom the end of surgery up to 1 week postoperativelyPresence/absence of hematoma postoperatively
Postsurgical bleedingFrom the end of surgery up to 1 week postoperativelyPresence/absence of bleeding postoperatively

Secondary

MeasureTime frameDescription
Implant survival ratesFrom the baseline (surgery procedure) up to 1 year post-surgeryImplant survival rates assessment at 1 year postoperatively.
Radiographic outcomesFrom the baseline (surgery procedure) up to 1 year post-surgeryRadiographic (CBCT) qualitative assessment of the gained volume (change in volume from baseline to 1 year postoperatively).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026